GenBio AI Unveils a Breakthrough World Model for Simulating Human Cells
On August 18, 2026, Palo Alto-based GenBio AI announced the preview release of the first general-purpose simulator and world model of the human cell called...
AI in Research
Featured
Selected coverage the editors think is worth your time, drawn from across the site.
77 articles
The Rise of the One-Person Pharma Company
AI can now design a molecule, a cloud lab can make and test it, and a regulatory on-ramp exists to put it into a patient....
AI in Research
Roche AXELIOS 1 Review Against the High-Throughput Pack
Roche launched the AXELIOS 1 platform yesterday, moving its sequencing-by-expansion (SBX) technology from years of early access at sites like the Broad and Hartwig into...
Featured
BoltzMol-1, BoltzProt-1 and the Boltz API: AI Drug Discovery Goes Full-Stack
The MIT-born co-folding lab just shipped a small-molecule hit-discovery pipeline, a protein-design pipeline, and a production API on the same day — moving from “we...
AI in Research
Laser Phase Plate Becomes Reality: Biohub and Berkeley Solve Cryo-EM’s 80-Year Contrast Problem with a Laser
After more than fifteen years of being dismissed as theoretically elegant but practically impossible, the laser phase plate (LPP) has been built, installed in a...
Featured
Human Longevity Drops a $599 Clinical-Grade Genome
Less than two weeks after the death of its co-founder Dr. J. Craig Venter on April 29, 2026, Human Longevity, Inc. (HLI) has launched a...
AI in Research
OpenAI Enters the AI-Bio Arms Race with GPT-Rosalind
OpenAI has officially unveiled GPT-Rosalind — its first frontier reasoning model purpose-built for biology, drug discovery, and translational medicine. Named after the British chemist Rosalind...
AI in Research
Qitan Tech vs Oxford Nanopore: Inside the Two-Horse Race for the Future of Nanopore Sequencing
For more than a decade, Oxford Nanopore Technologies was effectively alone in the commercial nanopore DNA sequencing, a market that it created. All that changed...
Featured